Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.

Clin Interv Aging · 2013 · PMC3677930 · PMID 23766636

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

failed to reach statistical significanceP = 0.058so close (0.05 < p ≤ 0.1)

However, bevacizumab seemed to fare slightly worse in terms of near VA, but the difference failed to reach statistical significance ( P = 0.058). 18 Diabetic macular edema The use of ranibizumab has been found to provide health-related quality of life gains in patients with DME.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.